2013 Q4 Form 10-Q Financial Statement

#000114420413061826 Filed on November 14, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q3
Revenue $1.085M $1.050M $1.056M
YoY Change 11.27% -0.6% -12.95%
Cost Of Revenue $1.119M $1.127M $1.077M
YoY Change -1.3% 4.7% -6.14%
Gross Profit -$33.91K -$77.31K -$20.43K
YoY Change -78.63% 278.5% -130.79%
Gross Profit Margin -3.12% -7.36% -1.93%
Selling, General & Admin $840.4K $1.010M $960.9K
YoY Change 6.16% 5.13% -0.67%
% of Gross Profit
Research & Development $170.0K $147.0K $141.5K
YoY Change 13.98% 3.9% -43.71%
% of Gross Profit
Depreciation & Amortization $180.0K $190.0K $220.0K
YoY Change 0.0% -13.64% -4.35%
% of Gross Profit
Operating Expenses $1.010M $1.157M $1.102M
YoY Change 7.4% 4.97% -5.67%
Operating Profit -$1.044M -$1.235M -$1.123M
YoY Change -5.01% 9.95% 1.86%
Interest Expense $86.00 $741.00 $130.0K
YoY Change -100.17% -99.43%
% of Operating Profit
Other Income/Expense, Net $117.4K -$36.39K $129.1K
YoY Change -313.94% -128.18% 138758.06%
Pretax Income -$930.0K -$1.270M -$990.0K
YoY Change -19.13% 28.28% -10.0%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$927.0K -$1.271M -$993.7K
YoY Change -19.7% 27.9% -9.85%
Net Earnings / Revenue -85.4% -121.05% -94.08%
Basic Earnings Per Share
Diluted Earnings Per Share -$24.25K -$35.36K -$29.23K
COMMON SHARES
Basic Shares Outstanding 38.42M shares 38.42M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.410M $5.280M $5.030M
YoY Change -0.68% 4.97% 216.35%
Cash & Equivalents $4.415M $5.284M $5.029M
Short-Term Investments
Other Short-Term Assets $160.0K $210.0K $200.0K
YoY Change -30.43% 5.0% -4.76%
Inventory $426.3K $436.2K $410.5K
Prepaid Expenses
Receivables $917.2K $962.3K $845.1K
Other Receivables $10.00K $10.00K $10.00K
Total Short-Term Assets $5.925M $6.902M $6.496M
YoY Change 3.28% 6.25% 82.48%
LONG-TERM ASSETS
Property, Plant & Equipment $1.349M $1.510M $2.210M
YoY Change -33.48% -31.69% -26.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $262.7K $271.4K $301.4K
YoY Change -12.75% -9.97% 67.47%
Total Long-Term Assets $2.263M $2.432M $3.163M
YoY Change -24.07% -23.09% -8.59%
TOTAL ASSETS
Total Short-Term Assets $5.925M $6.902M $6.496M
Total Long-Term Assets $2.263M $2.432M $3.163M
Total Assets $8.188M $9.335M $9.659M
YoY Change -6.07% -3.36% 37.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $430.0K $650.0K $350.0K
YoY Change 10.26% 85.71% -36.36%
Accrued Expenses $420.0K $320.0K $230.0K
YoY Change 40.0% 39.13% -37.84%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $847.3K $969.9K $578.4K
YoY Change 21.59% 67.69% -37.13%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $850.0K $950.0K $930.0K
YoY Change -15.0% 2.15% 36.76%
Total Long-Term Liabilities $850.0K $950.0K $930.0K
YoY Change -15.0% 2.15% 36.76%
TOTAL LIABILITIES
Total Short-Term Liabilities $847.3K $969.9K $578.4K
Total Long-Term Liabilities $850.0K $950.0K $930.0K
Total Liabilities $1.699M $1.920M $1.504M
YoY Change 0.27% 27.66% -5.99%
SHAREHOLDERS EQUITY
Retained Earnings -$54.29M -$53.36M -$49.23M
YoY Change 7.75% 8.4%
Common Stock $38.42K $38.42K $34.60K
YoY Change 11.0% 11.05%
Preferred Stock
YoY Change
Treasury Stock (at cost) $8.390K $8.390K $8.390K
YoY Change 0.0% 0.0%
Treasury Stock Shares 13.20K shares 13.20K shares 13.20K shares
Shareholders Equity $6.489M $7.415M $8.155M
YoY Change
Total Liabilities & Shareholders Equity $8.188M $9.335M $9.659M
YoY Change -6.07% -3.36% 37.59%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income -$927.0K -$1.271M -$993.7K
YoY Change -19.7% 27.9% -9.85%
Depreciation, Depletion And Amortization $180.0K $190.0K $220.0K
YoY Change 0.0% -13.64% -4.35%
Cash From Operating Activities -$850.0K -$892.0K -$938.6K
YoY Change 49.12% -4.97% 73.15%
INVESTING ACTIVITIES
Capital Expenditures -$20.00K $2.041K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities -$20.00K -$4.631K -$6.869K
YoY Change -32.58% -56.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $3.292M
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.00K $3.281M $3.302M
YoY Change 0.0% -0.62% 8103.74%
NET CHANGE
Cash From Operating Activities -850.0K -$892.0K -$938.6K
Cash From Investing Activities -20.00K -$4.631K -$6.869K
Cash From Financing Activities -10.00K $3.281M $3.302M
Net Change In Cash -880.0K $2.384M $2.356M
YoY Change 51.72% 1.2% -555.08%
FREE CASH FLOW
Cash From Operating Activities -$850.0K -$892.0K -$938.6K
Capital Expenditures -$20.00K $2.041K
Free Cash Flow -$830.0K -$894.1K -$938.6K
YoY Change 45.61% -4.75% 71.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q3 dei Amendment Flag
AmendmentFlag
false
CY2013Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2013Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2013Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2013Q3 dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
CY2013Q3 dei Document Type
DocumentType
10-Q
CY2013Q3 dei Entity Central Index Key
EntityCentralIndexKey
0000728387
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
38419502 shares
CY2013Q3 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013Q3 dei Entity Registrant Name
EntityRegistrantName
IsoRay, Inc.
CY2013Q3 isr Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
5648738 shares
CY2013Q3 isr Class Of Warrant Or Right Issued In Period Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightIssuedInPeriodExercisePriceOfWarrantsOrRights
0.72
CY2013Q3 isr Gross Proceeds From Issuance Of Stock
GrossProceedsFromIssuanceOfStock
3703527 USD
CY2013Q3 isr Payments For Underwriting Fees Costs
PaymentsForUnderwritingFeesCosts
185176 USD
CY2013Q3 isr Payments Of Stock Issuance Costs Legal And Accounting Expense
PaymentsOfStockIssuanceCostsLegalAndAccountingExpense
182917 USD
CY2013Q3 isr Payments Of Stock Issuance Costs Listing Expense
PaymentsOfStockIssuanceCostsListingExpense
48500 USD
CY2013Q3 isr Payments Of Stock Issuance Costs Other Expenses
PaymentsOfStockIssuanceCostsOtherExpenses
6046 USD
CY2013Q3 isr Provision For Reduction Of Doubtful Accounts
ProvisionForReductionOfDoubtfulAccounts
5001 USD
CY2012Q3 isr Provision For Reduction Of Doubtful Accounts
ProvisionForReductionOfDoubtfulAccounts
-51472 USD
CY2013Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
653390 USD
CY2013Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
432566 USD
CY2013Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
962256 USD
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
923780 USD
CY2013Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
111276 USD
CY2013Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
107578 USD
CY2013Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
60746730 USD
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
57431293 USD
CY2013Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
7685 USD
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34618517 shares
CY2012Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
7079 USD
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
38353 USD
CY2012Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
28963 USD
CY2013Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
47597 USD
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
52598 USD
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13156389 shares
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4341970 shares
CY2013Q3 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
17960 USD
CY2012Q3 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
16419 USD
CY2013Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
810202 USD
CY2013Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
792242 USD
CY2013Q3 us-gaap Assets
Assets
9334688 USD
CY2013Q2 us-gaap Assets
Assets
7055356 USD
CY2013Q3 us-gaap Assets Current
AssetsCurrent
6902360 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
4443660 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5284163 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2899927 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5028727 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2672711 USD
CY2013Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2384236 USD
CY2012Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2356016 USD
CY2013Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
0.89
CY2013Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
1.38
CY2013Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
7605771 shares
CY2013Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1957033 shares
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
192998329 shares
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
193000000 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38419502 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34618517 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38419502 shares
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
38420 USD
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
34618 USD
CY2013Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1127223 USD
CY2012Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1076657 USD
CY2013Q3 us-gaap Deferred Compensation Arrangement With Individual Fair Value Of Shares Issued
DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued
25150 USD
CY2013Q3 us-gaap Deferred Compensation Arrangement With Individual Fair Value Of Shares Issued
DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued
6906 USD
CY2013Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
176314 USD
CY2012Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
206393 USD
CY2013Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
140000 USD
CY2013Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
104000 USD
CY2013Q3 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <table style="MARGIN-BOTTOM: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-TOP: 0pt; WIDTH: 100%" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify"> <td style="WIDTH: 0px">&nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 0.5in"><strong>2.</strong></td> <td style="TEXT-ALIGN: justify"><strong>New Accounting Pronouncements</strong></td> </tr> </table> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <strong>&nbsp;</strong></p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (the "FASB") or other standards setting bodies that are adopted by us as of the specified effective dates. Unless otherwise discussed, we believe the impact of recently issued standards that are not yet effective will not have a material impact on our consolidated financial position, results of operations and cash flows upon adoption.</p> <!--EndFragment--></div> </div>
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2013Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2013Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
84933 USD
CY2013Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
127419 USD
CY2013Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P10M6D
CY2013Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
56060 USD
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
651036 USD
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
644853 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
-77308 USD
CY2012Q3 us-gaap Gross Profit
GrossProfit
-20425 USD
CY2013Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
220824 USD
CY2012Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-41499 USD
CY2013Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
33475 USD
CY2012Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
31514 USD
CY2013Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-42486 USD
CY2012Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-46424 USD
CY2013Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
30673 USD
CY2012Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-33881 USD
CY2013Q3 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-16999 USD
CY2012Q3 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
USD
CY2013Q3 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
12000 USD
CY2012Q3 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
12000 USD
CY2013Q3 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
3698 USD
CY2012Q3 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
5316 USD
CY2013Q3 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-2209 USD
CY2012Q3 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1215 USD
CY2013Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7524 USD
CY2012Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
56832 USD
CY2013Q3 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
18 USD
CY2012Q3 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
42 USD
CY2013Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
741 USD
CY2012Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6869 USD
CY2012Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
6 USD
CY2013Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
60847 USD
CY2013Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
42577 USD
CY2013Q3 us-gaap Inventory Net
InventoryNet
436244 USD
CY2013Q2 us-gaap Inventory Net
InventoryNet
405571 USD
CY2013Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
469758 USD
CY2013Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
469758 USD
CY2013Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
161011 USD
CY2013Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
167671 USD
CY2013Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
214386 USD
CY2013Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
195323 USD
CY2013Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
354 USD
CY2012Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
144 USD
CY2013Q3 us-gaap Liabilities
Liabilities
1920107 USD
CY2013Q2 us-gaap Liabilities
Liabilities
1689110 USD
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9334688 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7055356 USD
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
969905 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
792868 USD
CY2013Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3280888 USD
CY2012Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3301514 USD
CY2013Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4631 USD
CY2013Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-892021 USD
CY2012Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-938629 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-1270906 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-993668 USD
CY2013Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1999942 USD
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-996326 USD
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-36387 USD
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
129138 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
1157211 USD
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
1102381 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1234519 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1122806 USD
CY2012Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3291977 USD
CY2013Q3 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
1479431 USD
CY2012Q3 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
USD
CY2013Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
1801457 USD
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7001671 shares
CY2013Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8306 USD
CY2013Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
25305 USD
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
271394 USD
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
276507 USD
CY2013Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
112000 USD
CY2013Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
100000 USD
CY2013Q3 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
9293 USD
CY2013Q2 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
11502 USD
CY2013Q3 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2572 USD
CY2012Q3 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
6827 USD
CY2013Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2041 USD
CY2012Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
USD
CY2013Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2658 USD
CY2012Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2658 USD
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q3 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
726378 USD
CY2012Q3 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
USD
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
61 USD
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
59 USD
CY2013Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
210404 USD
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
202880 USD
CY2013Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
USD
CY2012Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
USD
CY2013Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3280888 USD
CY2013Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
USD
CY2012Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7746 USD
CY2013Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
USD
CY2012Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1791 USD
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1510009 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1684282 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
146990 USD
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
141472 USD
CY2013Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181167 USD
CY2013Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181149 USD
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-53362240 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-52091334 USD
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1049915 USD
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1056232 USD
CY2013Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
359185 USD
CY2012Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
316056 USD
CY2013Q3 us-gaap Share Based Compensation
ShareBasedCompensation
38353 USD
CY2012Q3 us-gaap Share Based Compensation
ShareBasedCompensation
28963 USD
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.58
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.59
CY2013Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2013Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.3231 pure
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.3231 pure
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0185 pure
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0177 pure
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.79
CY2013Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.59
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
7414581 USD
CY2013Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y9M26D
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
219581 USD
CY2013Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P4Y4M17D
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
203244 USD
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2278260 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.84
CY2013Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y9M
CY2013Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.58
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2080064 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.90
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
11400 USD
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
65000 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
50000 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
15000 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
222581 USD
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2370072 shares
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
5366246 USD
CY2012Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
18000 shares
CY2013Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
13200 shares
CY2013Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
13200 shares
CY2013Q3 us-gaap Treasury Stock Value
TreasuryStockValue
8390 USD
CY2013Q2 us-gaap Treasury Stock Value
TreasuryStockValue
8390 USD
CY2013Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-36000 USD
CY2012Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
129000 USD
CY2013Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
140000 USD
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35921712 shares
CY2012Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33866563 shares

Files In Submission

Name View Source Status
0001144204-13-061826-index-headers.html Edgar Link pending
0001144204-13-061826-index.html Edgar Link pending
0001144204-13-061826.txt Edgar Link pending
0001144204-13-061826-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
isr-20130930.xml Edgar Link completed
isr-20130930.xsd Edgar Link pending
isr-20130930_cal.xml Edgar Link unprocessable
isr-20130930_def.xml Edgar Link unprocessable
isr-20130930_lab.xml Edgar Link unprocessable
isr-20130930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v359332_10q.htm Edgar Link pending
v359332_ex31-1.htm Edgar Link pending
v359332_ex31-2.htm Edgar Link pending
v359332_ex32.htm Edgar Link pending